Raising awareness about glaucoma is crucial in India where it is the leading cause of irreversible blindness with at least 12 million people affected and almost 1.2 million people blind from the disease
The expansion is part of Lonza’s continued investment in its global manufacturing network, aiming to build a comprehensive offering for global customers
OxemiaTM (Desidustat) is an oral tablet formulation that is the first-in-India alternative to injectable erythropoietin-stimulating agents (ESAs)
Commits to plant 5000 trees in phase 1 with its partner SankalpTaru Foundation
First advanced hybrid closed-loop insulin pump system in India features automatic insulin delivery, automatic correction boluses, and bluetooth connectivity
The initiative brings internationally eminent cardiologists to increase awareness of health screening tests amongst pre-menopausal women
The approval marks the first-and-only immunotherapy-based treatment for use before surgery for non-small cell lung cancer
Dr. Muffazal Lakdawala performs the largest series of complete robotic gastric bypass surgery in India
It plans launch various other health monitoring tools for smartphones, making existing devices obsolete
Expands AbbVie's neuroscience portfolio, adding first-in-class modulators of the synaptic vesicle protein 2A, including lead molecule SDI-118 currently in Phase 1b studies
Subscribe To Our Newsletter & Stay Updated
